# Commercial Typhoid Tests Validation

> **NCT04673487** · — · UNKNOWN · sponsor: **Kenya Medical Research Institute** · enrollment: 2000 (estimated)

## Conditions studied

- Typhoid Fever

## Interventions

- **DIAGNOSTIC_TEST:** 1. SD Bioline Salmonella Typhi IgG/IgM Fast test, 2. Typhidot Rapid IgG/IgM combo test, 3. TUBEX TF test, 4.Typhoid IgG/IgM Combo Rapid Test CE, 5. Enterocheck WB test, 6. Test-itTM Typhoid IgM test

## Key facts

- **NCT ID:** NCT04673487
- **Lead sponsor:** Kenya Medical Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01
- **Primary completion:** 2021-06
- **Final completion:** 2021-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2020-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04673487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04673487, "Commercial Typhoid Tests Validation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04673487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*